226 related articles for article (PubMed ID: 36688654)
1. Minimal Antigenic Evolution after a Decade of Norovirus GII.4 Sydney_2012 Circulation in Humans.
Parra GI; Tohma K; Ford-Siltz LA; Eguino P; Kendra JA; Pilewski KA; Gao Y
J Virol; 2023 Feb; 97(2):e0171622. PubMed ID: 36688654
[TBL] [Abstract][Full Text] [Related]
2. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
[TBL] [Abstract][Full Text] [Related]
3. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.
Debbink K; Lindesmith LC; Donaldson EF; Costantini V; Beltramello M; Corti D; Swanstrom J; Lanzavecchia A; Vinjé J; Baric RS
J Infect Dis; 2013 Dec; 208(11):1877-87. PubMed ID: 23908476
[TBL] [Abstract][Full Text] [Related]
4. Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses.
Kendra JA; Tohma K; Ford-Siltz LA; Lepore CJ; Parra GI
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836574
[TBL] [Abstract][Full Text] [Related]
5. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
[TBL] [Abstract][Full Text] [Related]
6. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein.
Ford-Siltz LA; Tohma K; Alvarado GS; Kendra JA; Pilewski KA; Crowe JE; Parra GI
Front Immunol; 2022; 13():1040836. PubMed ID: 36389818
[TBL] [Abstract][Full Text] [Related]
8. Norovirus GII.4 strain antigenic variation.
Lindesmith LC; Donaldson EF; Baric RS
J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of GII.4 norovirus persistence in human populations.
Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and genetic diversity of norovirus infection in children hospitalized with acute gastroenteritis in East Java, Indonesia in 2015-2019.
Utsumi T; Lusida MI; Dinana Z; Wahyuni RM; Soegijanto S; Soetjipto ; Athiyyah AF; Sudarmo SM; Ranuh RG; Darma A; Juniastuti ; Yamani LN; Doan YH; Shimizu H; Ishii K; Matsui C; Deng L; Abe T; Katayama K; Shoji I
Infect Genet Evol; 2021 Mar; 88():104703. PubMed ID: 33401005
[TBL] [Abstract][Full Text] [Related]
11. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of noroviruses detected in Vietnamese children with acute gastroenteritis from 2012 to 2015.
Hoa-Tran TN; Nakagomi O; Dao ATH; Nguyen AT; Agbemabiese CA; Vu HM; Nakagomi T; Thanh NTH
J Med Microbiol; 2017 Jan; 66(1):34-45. PubMed ID: 28032544
[TBL] [Abstract][Full Text] [Related]
13. Within-host evolution results in antigenically distinct GII.4 noroviruses.
Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
[TBL] [Abstract][Full Text] [Related]
14. Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.
Huhti L; Blazevic V; Puustinen L; Hemming M; Salminen M; Vesikari T
Infect Genet Evol; 2014 Aug; 26():65-71. PubMed ID: 24837668
[TBL] [Abstract][Full Text] [Related]
15. Characterization of GII.4 noroviruses circulating among children with acute gastroenteritis in Pune, India: 2005-2013.
Kulkarni R; Patel A; Bhalla S; Chhabra P; Cherian S; Chitambar SD
Infect Genet Evol; 2016 Jan; 37():163-73. PubMed ID: 26611824
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology of norovirus associated with gastroenteritis and emergence of norovirus GII.4 variant 2012 in Japanese pediatric patients.
Thongprachum A; Chan-it W; Khamrin P; Saparpakorn P; Okitsu S; Takanashi S; Mizuguchi M; Hayakawa S; Maneekarn N; Ushijima H
Infect Genet Evol; 2014 Apr; 23():65-73. PubMed ID: 24508246
[TBL] [Abstract][Full Text] [Related]
17. Immune Imprinting Drives Human Norovirus Potential for Global Spread.
Lindesmith LC; Boshier FAT; Brewer-Jensen PD; Roy S; Costantini V; Mallory ML; Zweigart M; May SR; Conrad H; O'Reilly KM; Kelly D; Celma CC; Beard S; Williams R; Tutill HJ; Becker Dreps S; Bucardo F; Allen DJ; Vinjé J; Goldstein RA; Breuer J; Baric RS
mBio; 2022 Oct; 13(5):e0186122. PubMed ID: 36102514
[TBL] [Abstract][Full Text] [Related]
18. Re-emergence of a GII.4 Norovirus Sydney 2012 Variant Equipped with GII.P16 RdRp and Its Predominance over Novel Variants of GII.17 in South Korea in 2016.
Choi YS; Koo ES; Kim MS; Choi JD; Shin Y; Jeong YS
Food Environ Virol; 2017 Jun; 9(2):168-178. PubMed ID: 28120262
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity and epidemiology of Genogroup II noroviruses in children with acute sporadic gastroenteritis in Shanghai, China, 2012-2017.
Lu L; Zhong H; Xu M; Su L; Cao L; Jia R; Xu J
BMC Infect Dis; 2019 Aug; 19(1):736. PubMed ID: 31438883
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
